https://www.thebodypro.com/author/sony-salzman

Latest by Sony Salzman

Prison Cells
News

Strong Peer Networks in Prison Boost Overall Health, Study Finds

But other research links prisons themselves to mental health challenges and infectious disease outbreaks.

scientists working in a lab
News

'No Single Gay Gene': Major Study Unpacks the Complex Genetic Underpinnings of Same-Sex Behavior

"Genetics is less than half the story for sexual behavior, but it's still a contributing factor."

nurse preparing vaccine
News

The First In-Human Chlamydia Vaccine Trial Shows Positive Immune Response

A chlamydia infection makes HIV acquisition more likely.

Jared Baeten
Conference Coverage

What Does the HOPE Study Say About the Future of the Vaginal Ring for HIV Prevention?

The results were less favorable than expected, but experts -- and women who participated in the trial -- would like to see this prevention tool approved for use.

Full panel for HIV Treatment Research: New Drugs and More Efficient Regimens press conference
Conference Coverage

What's New in HIV Treatment: A Report on Updates from IAS 2019

Researchers reported hopeful news on regimens with lower treatment burdens and newly developed antiretrovirals.

pharmacist looking at list
Reference

Hepatitis C (HCV) Initial Treatment Recommendations: A Closer Look at the Options

Although several HCV drugs can cure almost all infections regardless of viral genotype, picking the right drug will depend on each patient's medical history, level of liver damage, and coinfections.

Christoph D. Spinner
Conference Coverage

DISCOVER PrEP Trial Finds F/TAF Has Superior Load Time and Tail Compared to F/TDF

But given cost concerns, advocates question whether the benefits are enough to warrant dumping F/TDF as the go-to PrEP option.

Ivana Beesham
Conference Coverage

Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

Fernanda Fernandes Fonseca and Meg Doherty at an IAS 2019 press conference
News

World Health Organization Updates Guidance on Dolutegravir After Reassuring Data Regarding Safety in Early Pregnancy

New study results leave many experts feeling they went too far in their concerns over birth defect risks associated with the drug.